← All Dossiers
Marble Health – Seed
FUNDED Fund: StoryHouse Fund I · Check: $20K · Post: $22.5M · Round: Seed
Dossier generated 2026-07-17 by /deal-dossier  ·  Deal record: recUMzYHtSlofrvKk  ·  Source: Airtable appjxAR3LPe3fkHOp

One-Liner & Thesis

Marble Health is the school-embedded distribution channel for teen mental health, converting counselor referrals into Medicaid-billed therapy sessions — a wedge that solves the two hardest problems in pediatric behavioral health simultaneously: parent-side access and payer-side reimbursement. The founders previously built Headway into the category-defining adult-therapy marketplace; here they are re-running that playbook against the K-12 population, where insurance is nearly universal (Medicaid covers ~75-80% of Marble's book) and school counselors serve as unsaturated, high-intent lead-gen at effectively zero CAC.

Signal since our December-2023 SAFE has been strong: NYC launched Q1 2024, expansion to hundreds of schools, 15,000+ therapy appointments facilitated by the Series A announcement, and a $15.5M Costanoa-led Series A at $75M post that converted our $20K SAFE from $1.55 to $3.86 per share — a 2.5x mark on ~13K shares. Original round syndicate (Khosla $2M, Town Hall $2M, Daybreak $400K) all followed on. StoryHouse's Fund I check was small (angel-scale) but got us into a round that was nominally full and is now a top-quartile Fund I position by IRR.

Investment Score & Recommendation

82 / 100
STRONG INVEST
Repeat healthcare-marketplace founders (Headway) with a differentiated schools-plus-Medicaid wedge, tier-1 syndicate, and a 3.3x paper markup 17 months in. Fund I check is small but the position is compounding well.
Momentum: Accelerating Red flags: 1/9 Confidence: HIGH
Market & TAM8/10
Weight 25%
Team & Founder9/10
Weight 25%
Product & Traction8/10
Weight 20%
Deal Terms & Return7/10
Weight 20%
VC Syndicate9/10
Weight 10%

Deal Box

Round Size
$5.05M
Valuation (Post, SAFE Cap)
$22.5M
Lead / Co-Investors
Costanoa Ventures, Khosla, Town Hall Ventures, Daybreak Ventures
SH Check
$20,000
Fund
StoryHouse Fund I
Funding Round
Seed (SAFE)
Investment Date
2023-12-01
Current Mark (post Series A)
~2.5x on 12,903 shares @ $3.86

Company Snapshot

Sector
Health & Life Sciences · Pediatric Behavioral Health
Headquarters
Seattle, Washington (NYC ops)
Year Founded
2023
Total Raised
$20.5M
Latest Valuation
$75M post (Series A, 2025)
Website
marblehealth.com
Status
Private · Active

Market Size

$92B
US Behavioral Health TAM Web
Cited in Series A announcement
$32.1B
Digital Mental Health 2026 Web
Projected $58.7B by 2030
16.3%
CAGR 2026–2030 Web
Digital mental health category
Now
Timing Web
Post-Covid youth mental health crisis

Marble sits at the intersection of two persistent tailwinds: a declared youth mental health crisis (Surgeon General advisory, elevated teen anxiety/depression prevalence) and a payer environment where Medicaid and commercial plans both reimburse pediatric therapy but where families historically could not access it. Marble's wedge is not creating supply of therapists — it is unlocking demand by using schools as the referral surface and insurance as the payment rail, so the addressable market is meaningfully larger than the "cash-pay teletherapy" slice most competitors target.

Competition

PlayerPositioningFundingEdge / Note
Marble HealthSchool-embedded, insurance-billed teen therapy (Medicaid-heavy)$20.5M
Hazel HealthSchool-based telehealth + mental health; acquired Little Otter Oct 2025$180M+Larger & broader; now consolidated with Marble's closest sub-scale peer
BrightlinePediatric behavioral health, employer/health-plan channel$212M+ (KKR-led round at $705M valuation)Employer channel vs. schools; has had headcount reductions
Charlie HealthVirtual IOP (intensive outpatient) for teens; higher acuity$150M+Different acuity tier; commercial insurance; not schools-first
Little OtterAge 0-14 virtual therapy + psychiatry (acquired by Hazel Health Oct 2025)$26M pre-acquisitionCash-pay + insurance; consumer-marketed; consolidated out

Moat: The school-counselor referral graph plus in-network Medicaid credentialing is genuinely operationally hard to replicate — it is the same distribution + reimbursement wedge Headway built for adults, applied to K-12.

Traction Metrics

$2M
Est. LTM Revenue Internal
Airtable est. (pre-Series A)
15,000+
Therapy Sessions Web
Cumulative since NYC launch
Hundreds
School Partners Web
As of Series A close
75-80%
Medicaid Mix Web
Share of billed sessions

Exit Potential

Strategic M&A
Likely Path
Payer, MSO, or health-services roll-up
5-7 yrs
Time to Liquidity
2030-2032 window
50-100x on cost
Return Scenario (SH check)
Base case: 15-25x; upside: category leader outcome

Directly relevant comp: Hazel Health's acquisition of Little Otter (Oct 2025) is the exact acquirer profile — a schools-first pediatric behavioral platform absorbing an adjacent virtual therapy provider — and confirms that this segment attracts strategic consolidation, not just IPO paths. Brightline hit a $705M valuation in a KKR-led round, framing a plausible late-stage growth-equity outcome. Given the $20K SAFE at a $22.5M cap converted at ~$1.55/share and the Series A cleared at $3.86/share, our position is already up 2.5x on paper; a $500M–$1B exit would net a 22-45x on the SH position — attractive DPI contribution for Fund I even at the small check size.

Founders

Daniel Ross
Co-Founder & CEO
Healthcare entrepreneur focused on building and scaling care-delivery businesses. Co-founder of Headway, the adult-therapy marketplace that became one of the defining venture-scale bets in mental health, before co-founding Marble to re-run the payer-plus-supply-side playbook for the pediatric population. HBS-trained; references describe him as "super sharp," "stable head on his shoulders," and a "10/10" recommendation from repeat-founder Varun Puri.
Jake Sussman
Co-Founder & COO
Operator with a background in workforce and healthcare systems; second Headway co-founder to make the jump into pediatric behavioral health with Marble. Leads GTM and school-partnership motion; per December-2023 sync notes, is the counterpart to Dan's clinical/product ownership and drove the referral-flow product build with an initial contract engineering team.

Open Questions & Risks

Next Steps

Latest Meeting Notes

2023-12-15 Post-Close Sync Round-process debrief; angel allocation held tight Expand
Post-close check-in with Dan on our process and future access. Dan is genuinely happy with StoryHouse's work; only larger allocation he'd rather have given was to Chelsea Clinton's fund. Learnings for us on how to compete for prestige-oriented founders going forward.
Full note

Check-in on wide-outreach process for angel allocation. Dan spoke to a bunch of folks and learned useful things; open to more curated in future but understood the volume-oriented approach given tough/rare ask.

On being first in line for next round: They are speaking to Chelsea Clinton's fund, which wants to invest more than there is available. If that does not work out we will get a piece, but it is not looking likely. Otherwise there is not much more to do — Dan is happy with our work.

Dan was impressed with the research done in the space; spoke to many counselors and shared notes along the way. Consumer-orientation angle he took feels differentiated in the syndicate.

Summary: Continue to be frustrated by the small allocation but not sure what else to do. Founders are very focused on brand/prestige. Learnings include appreciation for subject-matter expertise as a value-add and a differentiated value proposition beyond connectivity.

Source: Meeting Notes recTXSpYTdoNtA7h1
2023-12-05 Founder Sync Launch plan & asks: senior engineer + parent-side intros Expand
Pre-launch working session. Marble wants to be live in NYC Jan/Feb 2024. Two things to prove: low-CAC acquisition via school counselors, and unit economics via group therapy tilt. Dan on clinical, Jake on GTM.
Full note

Want to launch in NYC as quickly as possible — January or February. Two things to prove: acquiring kids at low cost via school counselors; once working with kids, tilt the service group toward groups (not pure groups, but needed for unit economics to work).

Jake taking lead on GTM piece; Dan on clinical piece. Jake has built mocks on the referral piece; contract engineer engaged to build the product.

Ask 1: hire a full-time engineer, director-level, mid-level with good startup chops; ability to hire under them; PM overlap ideal. Location preference NYC then Seattle then remote. Archetype: someone from a high-growth startup who was promoted multiple times.

Ask 2: struggling to get to parents whose kid does any therapy — ideally kids who went through a counselor rather than parents paying for out-of-network therapists. Follow-up: JDs and a blurb for the ask to parents.

Source: Meeting Notes recRxGfg0qpToTXPn
2023-12-04 Docs SAFE docs sent; syndicate confirmed Expand
Dan sent the SAFE package for our $20K allocation, plus formation docs and board consent. Confirmed lead syndicate: Khosla (Samir Kaul) $2M, Town Hall (Meera Mani) $2M, Daybreak (Rex Woodbury) $400K. No side letter / MRL — Dan is keeping the round intentionally clean.
Full note

Excited to have StoryHouse on the journey to make therapy accessible for millions of teens across the country. SAFE attached with a $20K allocation; company formation docs (bylaws etc.) shared along with board consent for the SAFE round.

No formal cap table yet; Dan and Jake split equity 50/50 at formation and created a 10% option pool. This round is the first financing for the company.

Allocations of SAFEs where things are finalized and cash is in the bank (leads): Khosla (Samir Kaul) $2M, Town Hall Ventures (Meera Mani) $2M, Daybreak Ventures (Rex Woodbury) $400K. Angel composition not yet finalized — ~$4.7M allocated with ~$300K left for high-profile strategics (targeting folks like Arne Duncan, Serena Williams's fund).

Cannot do a side letter or MRL — Marble is keeping this round as clean as possible and prioritized partners (including leads) willing to be flexible on that. No data room; the deck is the full set of materials for the round.

Source: Meeting Notes recaMnY27HJXbIF4g

Deal Timeline

Reference Calls

"He's awesome! I went on a walk with him this week, multi-time founder, in the middle of his raise, knows the mental health space really well, stable head on his shoulders. 10/10 would recommend."

— Varun Puri on Dan Ross · 2023-11-14 · Meeting Notes recuB19t5SETn5krL

"Dan and I went to HBS together — he's an awesome dude. We worked together for a semester on a project for our entrepreneurial sales & marketing class. Super sharp and thoughtful when critically evaluating business models and excellent at executing / operations."

— Shreesh Naik on Dan Ross · 2023-11-15 · Meeting Notes rec44G8sorsodIFsG

"I went to high school with him. Really smart, nice guy. Caught up several months back — sounds like he's been doing cool things in HRtech."

— Mollie Muller on Dan Ross · 2023-11-20 · Meeting Notes receqLqzkSsvrGfD5

Sources

  1. PRNewswire — Marble Raises $15.5M Series A to Scale Access to Youth Mental Health Care — Series A financing, syndicate, $92B TAM cite.
  2. MobiHealthNews — Youth mental health company Marble Health raises $15.5M — Series A details, session count.
  3. Forbes — Meet Marble: The Startup Helping Kids Get Therapy From Real Therapists, Not AI — Positioning and human-therapist thesis.
  4. TechFundingNews — Khosla-backed Marble scoops $15.5M — Medicaid mix (~75-80%), school channel details.
  5. Causeartist — Marble Raises $15.5M Series A for School Mental Health — School partner scale.
  6. Research and Markets — Digital Mental Health Market Report 2026 — 2026 market size ($32.06B) and 16.3% CAGR.
  7. Digital Native (Rex Woodbury) — Combatting the Teen Mental Health Crisis — Timing / tailwind context from Daybreak partner.
  8. CB Insights — Brightline hits $705M valuation; competitor landscape — Brightline valuation and pediatric behavioral peer set.
  9. Behavioral Health Business — Pediatric Mental Health Provider Marble Raises $15.5M — Market context, competitor consolidation.
  10. Town Hall Ventures — Marble portfolio page — Co-investor thesis on the wedge.